Avanafil ZPHC — 50 × 50 mg tablets

Avanafil — ultra-fast PDE-5 inhibitor
50 film-coated tablets × 50 mg
Rapid onset: peak effect in ~15 minutes, faster than sildenafil or tadalafil.
Selective action: higher PDE-5 vs PDE-6 selectivity → fewer visual side effects.
Research dosing (example): 50–200 mg orally, 15–30 min pre-stimulus; limited food interaction.
Cautions: do not combine with nitrates or potent α-blockers; monitor blood pressure.
QC: ≥99% API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.
*For laboratory research use only. Not approved as a medicinal product.*, Avanafil ZPHC — 50 × 50 mg tablets, 59, USD, ,